- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Orchestra Biomed Holdings Inc (OBIO)
Orchestra Biomed Holdings Inc stock price live, this page displays NASDAQ OBIO stock exchange data. View the OBIO premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Orchestra Biomed Holdings Inc real time stock price chart below.
What Is the Orchestra Biomed Holdings Inc Stock Price Today?
The Orchestra Biomed Holdings Inc stock price today is 3.200.
What Is the Stock Symbol for Orchestra Biomed Holdings Inc?
The stock symbol for Orchestra Biomed Holdings Inc is ""OBIO.""
What Stock Exchange Does Orchestra Biomed Holdings Inc Trade On?
Orchestra Biomed Holdings Inc is listed and trades on the NASDAQ stock exchange.
Is Orchestra Biomed Holdings Inc a Good Stock to Buy?
Determining whether Orchestra Biomed Holdings Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the OBIO quote. (ISIN: US68572M1062)
What Is the Orchestra Biomed Holdings Inc Stock Price Today?
The Orchestra Biomed Holdings Inc stock price today is 3.200.
What Is the Stock Symbol for Orchestra Biomed Holdings Inc?
The stock symbol for Orchestra Biomed Holdings Inc is ""OBIO.""
What Stock Exchange Does Orchestra Biomed Holdings Inc Trade On?
Orchestra Biomed Holdings Inc is listed and trades on the NASDAQ stock exchange.
Is Orchestra Biomed Holdings Inc a Good Stock to Buy?
Determining whether Orchestra Biomed Holdings Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the OBIO quote. (ISIN: US68572M1062)
NASDAQ
Currency in USD
3.200
+0.040(+1.27%)
Closed·
After Hours
3.2000.000(0.00%)
·
Fair Value
An estimate of a Orchestra Biomed Holdings's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.120
3.210
52 wk Range
2.370
8.300
OBIO Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
OBIO is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Orchestra Biomed Holdings's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.1203.210
52 wk Range
2.3708.300
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
OBIO Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Orchestra Biomed Holdings's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
13.571
Upside
+324.11%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Orchestra Biomed Holdings Inc Company Profile
Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States. The company’s flagship product candidates include Atrioventricular Interval Modulation, a bioelectronic therapy candidate designed to immediately, substantially, and persistently lower blood pressure; and Virtue Sirolimus AngioInfusion Balloon for the treatment of atherosclerotic artery disease. It also develops Cardiac Neuromodulation Therapy for heart failure, or potential treatment of clinical indications; and CNT-HF, a bioelectronic product candidate that aims to reduce chronic sympathetic nervous system activity in heart failure. In addition, the company offers FreeHold devices and additional minimally invasive surgery enabling devices; and Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and upper gastrointestinal endoscopy procedures. It has a collaboration agreement with Medtronic, Inc. for the development of AVIM therapy for the treatment of HTN in pacemaker-indicated patients; and a strategic collaboration with Terumo Corporation and Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. was founded in 2018 and is headquartered in New Hope, Pennsylvania.
Compare OBIO to Peers and Sector
Metrics to compare | OBIO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipOBIOPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.8x | −3.6x | −0.5x | |
PEG Ratio | 0.09 | −0.12 | 0.00 | |
Price/Book | 7.3x | 2.4x | 2.6x | |
Price / LTM Sales | 42.5x | 1.8x | 3.2x | |
Upside (Analyst Target) | 279.7% | 42.5% | 42.7% | |
Fair Value Upside | Unlock | 4.3% | 5.8% | Unlock |
Analyst Ratings
7 Buy
0 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 13.571
(+324.11% Upside)
Earnings
Latest Release
May 12, 2025
EPS / Forecast
-0.49 / -0.46
Revenue / Forecast
868.00K / 440.00K
People Also Watch
FAQ
What Stock Exchange Does Orchestra Biomed Holdings Trade On?
Orchestra Biomed Holdings is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Orchestra Biomed Holdings?
The stock symbol for Orchestra Biomed Holdings is "OBIO."
What Is the Orchestra Biomed Holdings Market Cap?
As of today, Orchestra Biomed Holdings market cap is 122.60M.
What Is Orchestra Biomed Holdings's Earnings Per Share (TTM)?
The Orchestra Biomed Holdings EPS (TTM) is -1.77.
From a Technical Analysis Perspective, Is OBIO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Orchestra Biomed Holdings Stock Split?
Orchestra Biomed Holdings has split 0 times.
How Many Employees Does Orchestra Biomed Holdings Have?
Orchestra Biomed Holdings has 70 employees.
What is the current trading status of Orchestra Biomed Holdings (OBIO)?
As of 23 Jul 2025, Orchestra Biomed Holdings (OBIO) is trading at a price of 3.20, with a previous close of 3.20. The stock has fluctuated within a day range of 3.12 to 3.21, while its 52-week range spans from 2.37 to 8.30.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.